Class III
Ongoing
AcetaZOLAMIDE Tablets, USP, 125 mg, 100 count bottled, Rx Only, Distributed by: Advagen Pharma Limited, Plainsboro, NJ, Manufactured by Rubicon Research Private Limited, Thane, India NDC 72888-047-01
This recall is currently active, issued September 25, 2024. It was issued by Rubicon Research Private Limited.
- Company
- Rubicon Research Private Limited
- Recall Initiated
- August 24, 2024
- Posted
- September 25, 2024
- Recall Number
- D-0659-2024
- Voluntary / Mandated
- Voluntary: Firm initiated
- Quantity
- 3,984 bottles
- Firm Location
- Ambarnath, India
- Official Source
- View on FDA website ↗
Reason for Recall
Discoloration
Distribution
Nationwide in the US
Lot / Code Info
Lot # 30575HF1, exp. date, Nov 2026 NDC# 72888-047-01
More recalls by Rubicon Research Private Limited
Other recent Class III Drug recalls
Eptifibatide Injection, 75 mg/100 mL vial for weight-adjusted bolus dosing, 1x100 mL Single-dose Via...
Slate Run Pharmaceuticals
· Mar 4, 2026
Doxazosin Tablets, USP, 4 mg, 1000 tablets per bottle, Rx only, distributed by Unichem Pharmaceutica...
Unichem Pharmaceuticals Usa Inc.
· Feb 18, 2026
parodontax (cetylpyridinium chloride)ACTIVE GUM HEALTH, Mouthwash, Mint. Net Wt 16.9 FL OZ (500 mL),...
Haleon Us Holdings Llc
· Feb 4, 2026
Glycopyrrolate Oral Solution, 1 mg/5 mL, 16 oz. (473 mL), Rx only, Manufactured by: MSN Pharmaceutic...
Novadoz Pharmaceuticals Llc
· Feb 4, 2026
Diclofenac Sodium Topical Gel, 1%, NET WT 100 g (3.53 oz), Manufactured by: DPT Laboratories, Ltd.,...
Cipla Usa, Inc.
· Jan 28, 2026